PACS insider plans $6.6M stock sale in 2026

Mark Hancock files a Rule 144 notice to sell 155,682 PACS Group common shares via Citigroup Global Markets, with over $6.6 million in stated aggregate market value.

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) is the issuer of common stock covered by a notice filed for the potential resale of restricted or control securities under Rule 144. The notice states that Mark Hancock plans to sell 155,682 shares of PACS common stock through Citigroup Global Markets Inc., with an aggregate market value of $6,612,032.49, after September 15, 2026 on the NYSE. PACS common stock outstanding is listed as 158,035,612 shares, which is a baseline figure, not the amount being sold. The filing also lists Hancock’s prior sales of PACS shares over the past three months.

Key Figures

Shares to be sold under Rule 144: 155,682 shares Aggregate market value of planned sale: $6,612,032.49 Shares outstanding: 158,035,612 shares +4 more

7 metrics

Shares to be sold under Rule 144 155,682 shares PACS common stock planned for sale through Citigroup Global Markets Inc.

Aggregate market value of planned sale $6,612,032.49 Value of 155,682 PACS common shares to be sold on or after September 15, 2026

Shares outstanding 158,035,612 shares PACS Group, Inc. common stock outstanding listed in the Form 144

Shares acquired at issuer formation 54,626,199 shares Common shares acquired from the issuer on March 1, 2023 for cash

Past sale example on June 15, 2026 153,254 shares for $5,568,759.95 One of multiple PACS common stock sales by Mark Hancock in the prior three months

Past sale example on September 14, 2026 144,318 shares for $6,432,859.40 Most recent PACS common stock sale listed before the new notice

Approximate date of sale for planned transaction September 15, 2026 Date from which the 155,682 PACS shares may be sold on the NYSE

Key Terms

Rule 144, aggregate market value, issuer, 10% Stockholder, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Common | Citigroup Global Markets Inc ... | 155682 | 6612032.49"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

issuer regulatory

"Shares acquired at formation of the issuer | Issuer"

10% Stockholder regulatory

"Officer Director 10% Stockholder"

Securities To Be Sold financial

"144: Securities To Be Sold Common | 03/01/2023"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for PACS Group, Inc. (PACS)?

It discloses that Mark Hancock has filed a notice under Rule 144 to sell 155,682 shares of PACS Group, Inc. common stock through Citigroup Global Markets Inc., with stated aggregate market value of $6,612,032.49, on or after September 15, 2026.

How many PACS (PACS) shares are planned for sale under this Form 144?

The notice lists 155,682 shares of PACS Group, Inc. common stock to be sold under Rule 144. These shares are to be sold through Citigroup Global Markets Inc. on the NYSE, with an indicated aggregate market value of $6,612,032.49.

What share count for PACS Group, Inc. (PACS) is shown as outstanding?

The Form 144 lists 158,035,612 shares of PACS Group, Inc. common stock as outstanding. This figure provides context for the issuer’s capital structure and is separate from the 155,682 shares that Mark Hancock has noticed for potential sale.

What PACS (PACS) stock sales has Mark Hancock made in the past three months?

The filing lists multiple sales of PACS common stock by Mark Hancock between June 15, 2026 and September 14, 2026, each showing shares sold and dollar amounts, including sales such as 153,254 shares for $5,568,759.95 on June 15, 2026 and 144,318 shares for $6,432,859.40 on September 14, 2026.

Who is the broker for the PACS Group, Inc. (PACS) shares in this Form 144?

The broker identified for the planned sale is Citigroup Global Markets Inc., located at 388 Greenwich Street, New York, New York 10013. The filing associates this broker with the planned sale of 155,682 shares of PACS Group, Inc. common stock on the NYSE.

When were the PACS (PACS) shares to be sold under Rule 144 originally acquired?

The Form 144 indicates that the common shares to be sold were acquired on March 1, 2023 at the formation of the issuer, from the issuer for cash. It also notes a holding of 54,626,199 shares acquired on that date in this context.

Who signed the PACS Group, Inc. (PACS) Form 144 notice?

The notice is signed “/s/ Mark Darrell Hancock”, with a date entry of September 15, 2026. The signature section also carries the standard warning that intentional misstatements or omissions of facts may constitute federal criminal violations under 18 U.S.C. 1001.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 08:15 PM Accepted by SEC EDGAR 09/15/2026 - 08:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014361
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PACS Group, Inc.
SEC File Number	001-42011
Address of Issuer	90 S. 400 W. SUITE 700 SALT LAKE CITY UTAH 84101
Phone	(801) 447-9829
Name of Person for Whose Account the Securities are To Be Sold	Hancock Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	155682	6612032.49	158035612	09/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	Shares acquired at formation of the issuer	Issuer			54626199	03/01/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/15/2026	153254	5568759.95
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/16/2026	83066	2982385.05
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/17/2026	63680	2248413.44
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/25/2026	138069	5567701.46
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/26/2026	61931	2508081.64
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/01/2026	6080	273716.13
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/02/2026	12825	577290.44
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/06/2026	142163	6444860.09
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/08/2026	20338	916611.29
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/09/2026	4966	223781.37
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/14/2026	10296	463680.36
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	07/15/2026	3332	150114.93
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	09/14/2026	144318	6432859.40

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Darrell Hancock
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)